RS50614B - Derivati 4-fenil-5-okso-1,4,5,6,7,8-heksahidrokvinolina kao medikamenti za tretman neplodnosti - Google Patents

Derivati 4-fenil-5-okso-1,4,5,6,7,8-heksahidrokvinolina kao medikamenti za tretman neplodnosti

Info

Publication number
RS50614B
RS50614B RSP-2008/0457A RSP20080457A RS50614B RS 50614 B RS50614 B RS 50614B RS P20080457 A RSP20080457 A RS P20080457A RS 50614 B RS50614 B RS 50614B
Authority
RS
Serbia
Prior art keywords
alkyl
group
alkoxy
phenyl
alkenyl
Prior art date
Application number
RSP-2008/0457A
Other languages
English (en)
Inventor
Willem Frederik Johan Karstens
Cornelis Marius Timmers
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of RS50614B publication Critical patent/RS50614B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Derivat 2-metil-4-fenil~5-okso-1,4,5,6,7,8-heksahidrokvinolina u skladu sa Formulom I naznačen time što:R1 je (l-6C)alkil. (2-6C)alkenil ili (2-6C)alkinil grupa; R2 je halogen;R3 je S02NR5R6 ili (l-4C)alkoksi grupa, opciono supstituisana sa jednim ili više atoma fluora; X je O ili NR7 grupa;R4 je R8-(2-8C)alkil, R8-(3-8C)alkenil, R8-(3-8C)alkinil ili R8-(2-4C)alkoksi- (2-4C)alkil grupa; Z je CN ili NO2 grupa;R5 i R6 su nezavisno H ili (l-4C)alkil grupa; iliR5 zajedno sa R6 i N za koji su vezani formiraju 3-8 člani zasićeni prsten koji opciono pored toga sadrži heteroatome izabrane od O i S;R8 je OH, (l-4C)alkoksi, NH2; NR9C(0)Rn, NR9S02RH ili C(0)NR9R10 grupa;R7 i R9 su nezavisno H ili (l-4C)alkil grupa;R10 je (l-4C)alkil,(l-4C)alkoksi(l-4C)alkil, ili fenil(l-4C)alkil ili (2-5C)heteroaril(l-4C)alkil grupa, obe opciono supstituisane na (hetero)aromatičnom prstenu sa jednim ili više supstituenata izabranih od OH, NH2, halogena, NO2, CF3, CN, (l-4C)alkil, (l-4C)alkoksi i (di)(l-4C)alkilamino grupe;R11 je (l-4C)alkil, (2-4C)alkenil, (2-4C)alkinil, (l-4C)alkoksi(l-4C)alkil, (3-6C)cikloalkil, (1-4C)alkoksi, (di)(l-4C) alkilamino ili fenil ili (2-5C)heteroaril grupa, obe opciono supstituisane na (hetero)aromatičnom prstenu sa jednim ili više supstituenata izabranih od OH, NH2, halogena, NO2, CF3, CN, (l-4C)alkil, (l-4C)alkoksi i (di)(l-4C)alkilamino grupe; ili njihova farmaceutski prihvatljiva so. Prijava sadrži još 8 patentnih zahteva.
RSP-2008/0457A 2005-05-04 2006-05-02 Derivati 4-fenil-5-okso-1,4,5,6,7,8-heksahidrokvinolina kao medikamenti za tretman neplodnosti RS50614B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05103741 2005-05-04
PCT/EP2006/061978 WO2006117371A1 (en) 2005-05-04 2006-05-02 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY

Publications (1)

Publication Number Publication Date
RS50614B true RS50614B (sr) 2010-06-30

Family

ID=34939698

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2008/0457A RS50614B (sr) 2005-05-04 2006-05-02 Derivati 4-fenil-5-okso-1,4,5,6,7,8-heksahidrokvinolina kao medikamenti za tretman neplodnosti

Country Status (31)

Country Link
US (1) US8017782B2 (sr)
EP (1) EP1879581B1 (sr)
JP (1) JP5118631B2 (sr)
KR (1) KR20080010445A (sr)
CN (1) CN101212971B (sr)
AR (1) AR054109A1 (sr)
AT (1) ATE406895T1 (sr)
AU (1) AU2006243194B2 (sr)
BR (1) BRPI0611124A2 (sr)
CA (1) CA2607106C (sr)
CY (1) CY1108584T1 (sr)
DE (1) DE602006002608D1 (sr)
DK (1) DK1879581T3 (sr)
ES (1) ES2313667T3 (sr)
HK (1) HK1110782A1 (sr)
HR (1) HRP20080488T3 (sr)
IL (1) IL186831A (sr)
MX (1) MX2007013754A (sr)
MY (1) MY144609A (sr)
NO (1) NO20075637L (sr)
NZ (1) NZ562804A (sr)
PE (1) PE20061371A1 (sr)
PL (1) PL1879581T3 (sr)
PT (1) PT1879581E (sr)
RS (1) RS50614B (sr)
RU (1) RU2403249C2 (sr)
SI (1) SI1879581T1 (sr)
TW (1) TW200716553A (sr)
UA (1) UA92009C2 (sr)
WO (1) WO2006117371A1 (sr)
ZA (1) ZA200709096B (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7994189B2 (en) * 2005-05-04 2011-08-09 N.V. Organon Dihydropyridine derivatives
UA92008C2 (en) * 2005-05-04 2010-09-27 Н.В. Органон 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
UA92007C2 (ru) * 2005-05-04 2010-09-27 Н.В. Органон Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности
TW200944523A (en) 2008-02-08 2009-11-01 Organon Nv (Dihydro)pyrrolo[2,1-a]isoquinolines
US8071587B2 (en) * 2009-05-27 2011-12-06 N. V. Organon (Dihydro)imidazoiso[5,1-A]quinolines
TW201116531A (en) 2009-07-29 2011-05-16 Organon Nv Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
US8431564B2 (en) 2009-07-29 2013-04-30 Merck Sharp & Dohme B.V. Ring-annulated dihydropyrrolo[2,1-α]isoquinolines
TW201116515A (en) 2009-07-31 2011-05-16 Organon Nv Dihydrobenzoindazoles

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1070162B (de) 1959-12-03 Farbwerke Hoechst Aktiengesellschaft vormals Meister Lucius &. Brüning, Frankfurt/M Verfahren zur Herstellung von 5 - Brom - 3 - nitro - 4 - hydroxybenzaldehyd bzw. 5 - Chlor - 3 - nitro - 4 - hydroxybenzaldehyd
US5455253A (en) * 1992-10-20 1995-10-03 Zeneca Limited Heterocyclic derivatives
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives
DE4430639A1 (de) 1994-08-29 1996-03-07 Bayer Ag Verwendung von 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten
GB9515445D0 (en) 1995-07-27 1995-09-27 Pharmacia Spa Dihydropyridine and pyridine derivatives and process for their preparation
EP0876349B1 (en) * 1995-10-19 2002-09-11 Takeda Chemical Industries, Ltd. Quinoline derivatives as gnrh antagonists
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
AU772373B2 (en) 1998-08-07 2004-04-22 Laboratoires Serono Sa FSH mimetics for the treatment of infertility
WO2002009706A1 (en) 2000-07-27 2002-02-07 Smithkline Beecham Corporation Agonists of follicle stimulating hormone activity
BR0210645A (pt) * 2001-07-02 2004-10-05 Akzo Nobel Nv Composto derivado de tetraidroquinolina, composição farmacêutica, e, uso do composto.
JP2003026630A (ja) 2001-07-13 2003-01-29 Taoka Chem Co Ltd カラーカプラー中間体用カルボン酸クロリド類の製造法
TWI322012B (en) * 2002-12-20 2010-03-21 Organon Nv Tetrahydroquinoline derivatives
UA92008C2 (en) * 2005-05-04 2010-09-27 Н.В. Органон 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
US7994189B2 (en) * 2005-05-04 2011-08-09 N.V. Organon Dihydropyridine derivatives
UA92007C2 (ru) * 2005-05-04 2010-09-27 Н.В. Органон Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности

Also Published As

Publication number Publication date
JP2008540379A (ja) 2008-11-20
DK1879581T3 (da) 2008-12-15
CA2607106A1 (en) 2006-11-09
JP5118631B2 (ja) 2013-01-16
CA2607106C (en) 2013-07-23
RU2403249C2 (ru) 2010-11-10
IL186831A (en) 2011-08-31
ATE406895T1 (de) 2008-09-15
AU2006243194A1 (en) 2006-11-09
CY1108584T1 (el) 2014-04-09
KR20080010445A (ko) 2008-01-30
AU2006243194A8 (en) 2006-11-09
EP1879581A1 (en) 2008-01-23
AU2006243194B2 (en) 2011-07-21
CN101212971B (zh) 2010-12-08
PL1879581T3 (pl) 2009-02-27
UA92009C2 (ru) 2010-09-27
US20080262033A1 (en) 2008-10-23
US8017782B2 (en) 2011-09-13
NZ562804A (en) 2009-11-27
ES2313667T3 (es) 2009-03-01
NO20075637L (no) 2008-01-29
ZA200709096B (en) 2008-09-25
AR054109A1 (es) 2007-06-06
MY144609A (en) 2011-10-14
RU2007144984A (ru) 2009-06-10
PE20061371A1 (es) 2006-12-19
HK1110782A1 (en) 2008-07-25
SI1879581T1 (sl) 2009-02-28
CN101212971A (zh) 2008-07-02
HRP20080488T3 (en) 2008-11-30
DE602006002608D1 (de) 2008-10-16
PT1879581E (pt) 2008-11-13
TW200716553A (en) 2007-05-01
IL186831A0 (en) 2008-02-09
MX2007013754A (es) 2008-01-24
WO2006117371A1 (en) 2006-11-09
EP1879581B1 (en) 2008-09-03
BRPI0611124A2 (pt) 2010-11-09

Similar Documents

Publication Publication Date Title
RS50614B (sr) Derivati 4-fenil-5-okso-1,4,5,6,7,8-heksahidrokvinolina kao medikamenti za tretman neplodnosti
HRP20160533T1 (hr) Indoli kao antivirusna sredstva respiratornog sincicijskog virusa
PE20220567A1 (es) Nuevos derivados piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen
RS54606B1 (sr) Derivati 1-fenil-2-piridinil alkil alkohola kao inhibitori fosfodiesteraze
ECSP067013A (es) 2-quinolil-oxazoles sustituidos útiles como inhibidores de pde4
RS51652B (sr) Derivati imidazo[1,2-a]piridin-2-karboksamida, njihovo dobijanje i njihova terapeutska primena
RS51795B (sr) 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidin-5-oni, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
AR060316A1 (es) Azaindoles de utilidad como inhibidores de janus quinasas
RS53156B (sr) N1-pirazolospiroketoni kao inhibitori acetil-coa karboksilaze
RS53500B1 (sr) Supstituisana jedinjenja n-(1h-indazol-4-il)imidazo[1,2-a]piridin-3-karboksamida kao cfms inhibitori
WO2009156861A3 (en) Substituted pyrimidone derivatives
WO2009010660A3 (fr) Indazoles substitues, leur preparation et leur utilisation en therapeutique
RS53108B (sr) Amino-1,3,5-triazini n-zamenjeni sa hiralnim bicikličnim radikalima, proces za njihovu pripremu, njihova jedinjenja i njihova primena kao herbicida i regulatora rasta biljaka
MX2009004920A (es) Nuevos derivados de aminopirimidina como inhibidores de plk1.
AR065863A1 (es) Derivados de imidazolidinona
AR046938A1 (es) Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares
RS54586B1 (sr) Jedinjenja triazolopiridina kao inhibitori pim kinaze
PE20081775A1 (es) Compuestos macrociclicos como inhibidores del factor viia
RS53317B (sr) Novi derivati (6-okso-1,6-dihidropirimidin-2-il)amida, njihovo dobijanje i njihova farmaceutska upotreba kao inhibitora fosforilacije akt (pkb)
RS50968B (sr) Derivati 4-fenil-5-okso-1,4,5,6,7,8-heksahidrohinolina kao medikamenti u lečenju neplodnosti
WO2009095792A3 (en) Substituted heteroarylamide diazepinopyrimidone derivatives
RS54858B1 (sr) Antagonisti trpv4
ATE478885T1 (de) Pharmazeutische dopamin-glykokonjugat- zusammensetzungen und verfahren zu deren herstellung
DE14760712T1 (de) Pyridopyrimidin- oder Pyrimidopyrimidlnverbindung, Herstellungsverfahren, PharmazeutischeZusammensetzung und Verwendung davon
AR066605A1 (es) Derivados de heteroarilamida pirimidona